Skip to content
SNY·Nasdaq·US

Sanofi

Sanofi is a global pharmaceutical company that develops and sells prescription medicines and vaccines. Its portfolio includes immunology, rare diseases, oncology, and immunization products, with vaccines and specialty medicines as major revenue streams.

Recent Activity

Updated Oct 31, 2026
–Sanofi Healthcare received marketing authorisation from India's drug regulator CDSCO for Qfitlia, a therapy to prevent bleeding in haemophilia A and B patients aged 12 and older.
–Qfitlia offers bleed protection with six annual injections.

Past updates are part of the Pro plan.

Thematic Position

SNY

Relationship Groups

Suppliers3
Customers1
Partners25
Licensing11
Competitors25

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

9 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

price controltariff exemptionMFN pricing
Sanofi voluntary MFN agreement with US government constrains commercial pricing flexibility
SEC 20-FFeb 17, 2026

The full regulatory passage is part of the Pro plan.

19 more · Regulatory and geopolitical insights are part of the Pro plan.